Postmarketing Safety Surveillance of a Hexavalent Vaccine in the Vaccine Adverse Event Reporting System

被引:0
作者
Moro, Pedro L. [1 ,3 ]
Zhang, Bicheng [1 ]
Marquez, Paige [1 ]
Reich, Jonathan [2 ]
机构
[1] Div Healthcare Qual Promot CDC, Immunizat Safety Off, Silver Spring, MD USA
[2] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA
[3] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Immunizat Safety Off, 1600 Clifton Rd,MS D26, Atlanta, GA 30333 USA
关键词
CLINICAL-TRIAL; DOUBLE-BLIND; IMMUNOGENICITY; INTUSSUSCEPTION; TOLERABILITY; DIPHTHERIA; PERTUSSIS; TETANUS; RISK;
D O I
10.1016/j.jpeds.2023.113643
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We assessed the safety of hexavalent vaccine diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, hepatitis b, and haemophilus influenzae b conjugate vaccine in the Vaccine Adverse Event Reporting System. Five hundred-one reports of adverse events (AEs) were identified; 21 (4.2%) were serious. Most frequently reported AEs were fever (10.2%) and injection site erythema (5.4%). AEs reported were consistent with findings from prelicensure studies. (J Pediatr 2023;262:113643).
引用
收藏
页数:4
相关论文
共 50 条
[11]   Major Birth Defects after Vaccination Reported to the Vaccine Adverse Event Reporting System (VAERS), 1990 to 2014 [J].
Moro, Pedro L. ;
Cragan, Janet ;
Lewis, Paige ;
Sukumaran, Lakshmi .
BIRTH DEFECTS RESEARCH, 2017, 109 (13) :1057-1062
[13]   Data Mining in the US using the Vaccine Adverse Event Reporting System [J].
John Iskander ;
Vitali Pool ;
Weigong Zhou ;
Roseanne English-Bullard .
Drug Safety, 2006, 29 :375-384
[14]   Adverse Events following Haemophilus influenzae Type b Vaccines in the Vaccine Adverse Event Reporting System, 1990-2013 [J].
Moro, Pedro L. ;
Jankosky, Christopher ;
Menschik, David ;
Lewis, Paige ;
Duffy, Jonathan ;
Stewart, Brock ;
Shimabukuro, Tom T. .
JOURNAL OF PEDIATRICS, 2015, 166 (04) :992-997
[15]   Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015 [J].
Arana, Jorge E. ;
Harrington, Theresa ;
Cano, Maria ;
Lewis, Paige ;
Mba-Jonas, Adamma ;
Li Rongxia ;
Stewart, Brock ;
Markowitz, Lauri E. ;
Shimabukuro, Tom T. .
VACCINE, 2018, 36 (13) :1781-1788
[16]   Association rule mining in the US Vaccine Adverse Event Reporting System (VAERS) [J].
Wei, Lai ;
Scott, John .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 (09) :922-933
[17]   Adverse events after Fluzone® Intradermal vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2011-2013 [J].
Moro, Pedro L. ;
Harrington, Theresa ;
Shimabukuro, Tom ;
Cano, Maria ;
Museru, Oidda I. ;
Menschik, David ;
Broder, Karen .
VACCINE, 2013, 31 (43) :4984-4987
[18]   Intussusception after monovalent rotavirus vaccine-United States, Vaccine Adverse Event Reporting System (VAERS), 2008-2014 [J].
Haber, Penina ;
Parashar, Umesh D. ;
Haber, Michael ;
DeStefano, Frank .
VACCINE, 2015, 33 (38) :4873-4877
[19]   Adverse events with risankizumab in the real world: postmarketing pharmacovigilance assessment of the FDA adverse event reporting system [J].
Shu, Yamin ;
Chen, Jing ;
Ding, Yiling ;
Zhang, Qilin .
FRONTIERS IN IMMUNOLOGY, 2023, 14
[20]   Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007-2017 [J].
Moro, Pedro L. ;
Arana, Jorge ;
Marquez, Paige L. ;
Ng, Carmen ;
Barash, Faith ;
Hibbs, Beth F. ;
Cano, Maria .
VACCINE, 2019, 37 (28) :3730-3734